Leland Stanford Junior University

University of Minnesota

Michael E Moseley

John Kucharczyk

Norbert Joseph Pelc

Charles Loeb Truwit

Haiying Liu

Roland Bammer

Burak Acar

Michael Markl

Mohammad Mehdi Khalighi

John D E Gabrieli

Maj Hedehus

Torkel Klingberg

Russell A Poldrack

A method for PET image reconstruction acquires PET data by a PET scanner; reconstructs from the acquired PET data a seed PET image; builds a feature space from the seed PET image and anatomical images co-registered with the seed PET image; performs a penalized maximum-likelihood reconstruction of a PET image from the seed PET image and the feature space using a penalty function that is calculated based on the differences between each voxel and its neighbors both on the PET image and in the feature space regardless of their location in the image.

Feature space based MR guided PET reconstruction

Non-invasive imaging methods and minimally invasive sensing methods are used for assessing the viability of cells implanted in the central nervous system for therapeutic purposes and for detecting the transformation of such cells, including embryonic stem cells, into brain tumors. In particular, the present invention provides an imaging means for differentiating normal cell proliferation and angiogenesis following a cell implant from abnormal tumor growth and neovascularization associated with teratoma-inducing implanted embryonic stem cells.

Imaging methods for early detection of brain tumors following embryonic stem cell implants

The invention is an apparatus and method for treatments and targeted drug delivery into a living patient, particularly but not exclusively using magnetic resonance (MR) imaging. The apparatus and method are useful in delivery to all types of living tissue and uses MR Imaging to track the location of drug delivery and estimating the rate of drug delivery. An MR-visible drug delivery device positioned at a target site (e.g., intracranial delivery) delivers a diagnostic or therapeutic drug solution into the tissue (e.g., the brain). The spinal distribution kinetics of the injected or infused drug agent are monitored quantitatively and non-invasively using water proton directional diffusion MR imaging to establish the efficacy of drug delivery at a targeted location.

Magnetic resonance apparatus for use with active electrode and drug deliver catheter

A catheter is used for medical treatments within an organism. The catheter comprises at least one lumen. Within the at least one lumen are at least two microcatheters, with at least one of the at least two microcatheters being connected to a source of liquid material to be delivered to the organism and another of the at least two microcatheters being connected to a system capable of effecting a medical treatment other than delivery of the liquid.

MR-compatible devices

A general mathematical framework is formulated to characterize the contribution of gradient non-uniformities to diffusion tensor imaging in MRI. Based on a model expansion, the actual gradient field is approximated and employed, after elimination of geometric distortions, for predicting and correcting the errors in diffusion encoding. Prior to corrections, experiments clearly reveal marked deviations of the calculated diffusivity for fields of view generally used in diffusion experiments. These deviations are most significant with greater distance from the magnet's isocenter. For a FOV of 25 cm the resultant errors in absolute diffusivity can range from approximately &#x2212;10 to +20 percent. Within the same field of view, the diffusion-encoding direction and the orientation of the calculated eigenvectors can be significantly altered if the perturbations by the gradient non-uniformities are not considered. With the proposed correction scheme most of the errors introduced by gradient non-uniformities can be removed.

Correction of the effect of spatial gradient field distortions in diffusion-weighted imaging

A method of detecting a neurological disorder such as dyslexia includes the steps of measuring microstructure of cerebral white matter, and correlating the microstructure to the presence of the neurological disorder. For dyslexia, the white matter is confined to temporo-parietal white matter. The microstructure is measured by determining cerebral white matter anisotropy using diffusion tensor magnetic resonance imaging (DTI).

Analysis of cerebral white matter for prognosis and diagnosis of neurological disorders

The invention is an apparatus and method for targeted drug delivery into a living patient using magnetic resonance (MR) imaging. The apparatus and method are useful in delivery to all types of living tissue and uses MR Imaging to track the location of drug delivery and estimating the rate of drug delivery. An MR-visible drug delivery device positioned at an target site (e.g., intracranial delivery) delivers a diagnostic or therapeutic drug solution into the tissue (e.g., the brain). The spatial distribution kinetics of the injected or infused drug agent are monitored quantitatively and non-invasively using water proton directional diffusion MR imaging to establish the efficacy of drug delivery at a targeted location.

Growing community of inventors

Redwood City, CA, United States of America

Michael E Moseley